106 related articles for article (PubMed ID: 21971370)
1. Blood pressure modulation following activation of mast cells by cationic cell penetrating peptides.
Basheer M; Schwalb H; Shefler I; Levdansky L; Mekori YA; Gorodetsky R
Peptides; 2011 Dec; 32(12):2444-51. PubMed ID: 21971370
[TBL] [Abstract][Full Text] [Related]
2. Translocation properties of novel cell penetrating transportan and penetratin analogues.
Lindgren M; Gallet X; Soomets U; Hällbrink M; Bråkenhielm E; Pooga M; Brasseur R; Langel U
Bioconjug Chem; 2000; 11(5):619-26. PubMed ID: 10995204
[TBL] [Abstract][Full Text] [Related]
3. Passage of cell-penetrating peptides across a human epithelial cell layer in vitro.
Lindgren ME; Hällbrink MM; Elmquist AM; Langel U
Biochem J; 2004 Jan; 377(Pt 1):69-76. PubMed ID: 12968950
[TBL] [Abstract][Full Text] [Related]
4. Suppression of adenosine A(3) receptor-mediated hypotension and mast cell degranulation in the rat by dexamethasone.
Hannon JP; Tigani B; Schuurman HJ; Fozard JR
J Pharmacol Exp Ther; 2002 Aug; 302(2):725-30. PubMed ID: 12130737
[TBL] [Abstract][Full Text] [Related]
5. Transportan-derived cell-penetrating peptide delivers siRNA to inhibit replication of influenza virus in vivo.
Zhang C; Ren W; Liu Q; Tan Z; Li J; Tong C
Drug Des Devel Ther; 2019; 13():1059-1068. PubMed ID: 31040643
[TBL] [Abstract][Full Text] [Related]
6. Label-Free Confocal Raman Mapping of Transportan in Melanoma Cells.
Cosme PJ; Ye J; Sears S; Wojcikiewicz EP; Terentis AC
Mol Pharm; 2018 Mar; 15(3):851-860. PubMed ID: 29397737
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activities and action mechanism studies of transportan 10 and its analogues against multidrug-resistant bacteria.
Xie J; Gou Y; Zhao Q; Li S; Zhang W; Song J; Mou L; Li J; Wang K; Zhang B; Yang W; Wang R
J Pept Sci; 2015 Jul; 21(7):599-607. PubMed ID: 25891396
[TBL] [Abstract][Full Text] [Related]
8. Identification of cell-penetrating peptides that are bactericidal to Neisseria meningitidis and prevent inflammatory responses upon infection.
Eriksson OS; Geörg M; Sjölinder H; Sillard R; Lindberg S; Langel U; Jonsson AB
Antimicrob Agents Chemother; 2013 Aug; 57(8):3704-12. PubMed ID: 23689723
[TBL] [Abstract][Full Text] [Related]
9. Desloratadine prevents compound 48/80-induced mast cell degranulation: visualization using a vital fluorescent dye technique.
Wang YH; Taché Y; Harris AG; Kreutner W; Daly AF; Wei JY
Allergy; 2005 Jan; 60(1):117-24. PubMed ID: 15575942
[TBL] [Abstract][Full Text] [Related]
10. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects.
Theoharides TC; Singh LK; Boucher W; Pang X; Letourneau R; Webster E; Chrousos G
Endocrinology; 1998 Jan; 139(1):403-13. PubMed ID: 9421440
[TBL] [Abstract][Full Text] [Related]
11. Mast cell degranulation in rat mesenteric venule: effects of L-NAME, methylene blue and ketotifen.
Kimura M; Mitani H; Bandoh T; Totsuka T; Hayashi S
Pharmacol Res; 1999 May; 39(5):397-402. PubMed ID: 10328998
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment with Evans blue, a stimulator of BK(Ca) channels, inhibits compound 48/80-induced shock, systemic inflammation, and mast cell degranulation in the rat.
Fu YS; Kuo SY; Lin HY; Chen CL; Huang SY; Wen ZH; Lee KZ; Huang HT
Histochem Cell Biol; 2015 Sep; 144(3):237-47. PubMed ID: 26003544
[TBL] [Abstract][Full Text] [Related]
13. Enantiomer-specific bioactivities of peptidomimetic analogues of mastoparan and mitoparan: characterization of inverso mastoparan as a highly efficient cell penetrating peptide.
Jones S; Howl J
Bioconjug Chem; 2012 Jan; 23(1):47-56. PubMed ID: 22148546
[TBL] [Abstract][Full Text] [Related]
14. Contribution of mast cells to cerebral aneurysm formation.
Ishibashi R; Aoki T; Nishimura M; Hashimoto N; Miyamoto S
Curr Neurovasc Res; 2010 May; 7(2):113-24. PubMed ID: 20334612
[TBL] [Abstract][Full Text] [Related]
15. Exploration of the Key Factors for Optimizing the in Vivo Oral Delivery of Insulin by Using a Noncovalent Strategy with Cell-Penetrating Peptides.
Kamei N; Shigei C; Hasegawa R; Takeda-Morishita M
Biol Pharm Bull; 2018; 41(2):239-246. PubMed ID: 29386483
[TBL] [Abstract][Full Text] [Related]
16. Cargo delivery kinetics of cell-penetrating peptides.
Hällbrink M; Florén A; Elmquist A; Pooga M; Bartfai T; Langel U
Biochim Biophys Acta; 2001 Dec; 1515(2):101-9. PubMed ID: 11718666
[TBL] [Abstract][Full Text] [Related]
17. Intracellular delivery of siRNA by cell-penetrating peptides modified with cationic oligopeptides.
Ishihara T; Goto M; Kodera K; Kanazawa H; Murakami Y; Mizushima Y; Higaki M
Drug Deliv; 2009 Apr; 16(3):153-9. PubMed ID: 19514975
[TBL] [Abstract][Full Text] [Related]
18. Anti-allergic activity of 2,4,6-trihydroxy-3-geranylacetophenone (tHGA) via attenuation of IgE-mediated mast cell activation and inhibition of passive systemic anaphylaxis.
Tan JW; Israf DA; Harith HH; Md Hashim NF; Ng CH; Shaari K; Tham CL
Toxicol Appl Pharmacol; 2017 Mar; 319():47-58. PubMed ID: 28167223
[TBL] [Abstract][Full Text] [Related]
19. Mast cell activation by fibrinogen-related homologous c-terminal peptides (haptides) modulates systemic blood pressure.
Basheer M; Schwalb H; Nesher M; Gilon D; Shefler I; Mekori YA; Shapira OM; Gorodetsky R
J Allergy Clin Immunol; 2010 Nov; 126(5):1041-8. PubMed ID: 20832847
[TBL] [Abstract][Full Text] [Related]
20. Novel mastoparan analogs induce differential secretion from mast cells.
Farquhar M; Soomets U; Bates RL; Martin A; Langel U; Howl J
Chem Biol; 2002 Jan; 9(1):63-70. PubMed ID: 11841939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
